Functional characterization of the V9D and R10C substitutions in chicken ARF. by Doreen Schwochow Thalmann (3912649)

“…In the experiment, ARF peptides (WT, V9D, and R10C, respectively) were titrated into 100 μM MDM2_204-298 with the peptide concentration increasing by approximately 10 μM in each titration point. …”

The top 100 TCs with highest RR for all-cause, CVDs, and RDs mortality. by Wenzhong Huang (538470)

Opa1 and Marf depletion leads to fragmented mitochondria and overexpression of Drp1^SD leads to clustered mitochondria in type II NBs. by Dnyanesh Dubal (12085942)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

“…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”

Heatmaps from relative expression of miRNAs, using as a metric the euclidean distance calculated between each PC bag and storage periods for hierarchical cluster construction. by Thaís Brilhante Pontes (762387)

“…(A) A sample of the relative expression of 100 PC bags were hierarchically clustered and scored as statistically significant p <0.001 for six periods of storage, showing that miR-127, was shown to be down-regulated in most PC bags experimentally validated. …”

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Induction level of the ORFs and the number of the regulated HITS. by Mohamad Karaky (8910497)

Subjects:

Flow chart of the expression-based functional screen, with validation steps. by Mohamad Karaky (8910497)

Subjects:

Transcription factor binding site analysis of HITS upregulated by different IBD-ORFs by PRIMA-EXPANDER. by Mohamad Karaky (8910497)

Subjects:

Selection of genes to include in expression screen. by Mohamad Karaky (8910497)

Subjects:

The impact of different concentrations of PTGIR antagonist on CP genes expression in THP1. by Mohamad Karaky (8910497)

Subjects:

Genetic data of the 5 loci of PTGIR, ZBTB40, NFKB1, SLC39A11 and PTGER4. by Mohamad Karaky (8910497)

Subjects:

Generation of a hiPSC-derived monocytic model. by Mohamad Karaky (8910497)

Subjects:

S4 Table - by Mohamad Karaky (8910497)

Subjects:

S3 Table - by Mohamad Karaky (8910497)

Subjects:

Shared impact on transcriptome for the ORFs ETS2 and ZBTB40. by Mohamad Karaky (8910497)

Subjects:

Transcription factor binding site analysis of HITS upregulated by different IBD-ORFs by gProfiler. by Mohamad Karaky (8910497)

Subjects:

Shared impact on transcriptome for the ORFs PTGIR, NFKB1, SLC39A11 and ZBTB40. by Mohamad Karaky (8910497)

Subjects:

Impact of LPS on PTGIR expression in THP-1. by Mohamad Karaky (8910497)

Subjects:

Forward and reverse primer sequences 5´-3´ used in the study. by Mohamad Karaky (8910497)

Subjects: